Breast cancer (BC) is highly heterogeneous with ~ 60–70% of estrogen receptor positive BC patient’s response to anti-hormone therapy. Estrogen receptors (ERs) play an important role in breast cancer progression and treatment. | Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer